XML 60 R39.htm IDEA: XBRL DOCUMENT v3.6.0.2
Variable Interest Entities (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2016
Dec. 31, 2015
Percent of pharmaceutical product's cash flow to be received by the limited partnership 84.00%    
Income (loss) from equity method investments   $ 6,219 $ 5,884
Proceeds from equity method investment, dividends or distributions   7,222 6,940
Payments to noncontrolling interests   3,696 3,575
Minimum Interest [Member]      
Percent of pharmaceutical product's cash flow to be received by the limited partnership 39.00%    
Non-controlling Interests in Consolidated Entities [Member]      
Investments in advance to affiliates, subsidiaries, associates, and joint ventures $ 7,000    
Payments to noncontrolling interests   3,696 3,575
SWKHP Holdings [Member]      
Income (loss) from equity method investments   $ 3,200 $ 3,000
Holmdel Pharmaceuticals LP [Member]      
Payments to acquire intangible assets $ 13,000    
Percentage of ownership by parent 46.00%    
SWKHP Holdings LP [Member]      
Investments in advance to affiliates, subsidiaries, associates, and joint ventures $ 13,000    
SWKHP Holdings GP [Member]      
Investments in advance to affiliates, subsidiaries, associates, and joint ventures $ 6,000